Living Cell Technologies announced positive results from a trial in Russia, two people were injected with insulin-producing cells from the pancreas of piglets. The company said the potential diabetes treatment caused a 25% decline in the daily insulin requirements of the patients. DiabeCell uses a seaweed-based gel coating on the cells to allow glucose in and insulin out but protect against being destroyed by the patient's immune system.

Related Summaries